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Occurrence of potentially zoonotic
and cephalosporin resistant enteric bacteria
among shelter dogs in the Central and SouthCentral Appalachia
Ashutosh Verma1,2*, Kimberly Carney1,3, Marina Taylor1, Kaitlyn Amsler1, Joey Morgan1, Karen Gruszynski1,3,
Erdal Erol4, Craig Carter4, Stephan Locke4, Ashton Callipare1 and Devendra H. Shah5*

Abstract
Background: Antimicrobial resistance and presence of zoonotic enteropathogens in shelter dogs pose a public
health risk to shelter workers and potential adopters alike. In this study we investigated the prevalence of zoonotic
bacterial pathogens and cephalosporin resistant (CefR) enteric bacteria in the feces of apparently healthy shelter dogs
in the Cumberland Gap Region (CGR) in the US states of Kentucky, Tennessee and Virginia.
Results: Fecal samples of 59 dogs from 10 shelters in the CGR of Central and South-Central Appalachia were
screened for the presence of Campylobacter jejuni, Clostridium perfringens, Salmonella and C
 efR enteric bacteria. C.
jejuni, C. perfringens were detected by PCR based assays. Culture and PCR were used for Salmonella detection. Of 59
dogs, fecal samples from 14 (23.7%) and 8 (13.6%) dogs tested positive for cpa and hipO genes of C. perfringens and C.
jejuni, respectively. Salmonella was not detected in any of the tested samples by PCR or culture. C
 efR enteric bacteria
were isolated on MacConkey agar supplemented with ceftiofur followed by identification using MALDI-TOF. Fecal
samples from 16 dogs (27.1%) yielded a total of 18 CefR enteric bacteria. Majority of CefR isolates (14/18, 77.8%) were E.
coli followed by, one isolate each of Enterococcus hirae, Acinetobacter baumannii, Acinetobacter pittii, and Pseudomonas
aeruginosa. CefR enteric bacteria were tested for resistance against 19- or 24-antibiotic panels using broth microdilution method. Seventeen (94.4%) CefR bacteria were resistant to more than one antimicrobial agent, and 14 (77.8%)
displayed multidrug resistance (MDR).
Conclusions: This study shows that shelter dogs within the CGR not only carry zoonotic bacterial pathogens, but
also shed multidrug resistant enteric bacteria in their feces that may pose public health risks.
Keywords: Shelter dogs, Central and South-Central Appalachia, Multi-drug resistance (MDR), Antimicrobial resistance
(AMR)
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Background
Cephalosporin-resistant enteropathogens are prevalent
worldwide and are a formidable threat to both public
and animal health as many exhibit multi-drug resistance (MDR) [1]. This is concerning because extendedspectrum cephalosporins are listed as key antibiotics
for treatment of bacterial infections in both humans
and animals [2, 3]. Companion animals can serve as a
reservoir of anti-microbial resistant (AMR) bacteria
that have an increased potential for zoonotic transmission due to their intimate contact with humans [4–7].
While previous research on companion animal reservoirs for AMR has focused on clinically ill animals [4,
8, 9], the literature on the fecal analysis of healthy dogs,
especially shelter dog population in the United States is
lacking [10]. The 2019-2020 APPA National Pet Owners Survey reported 19% dogs obtained from animal
shelter/humane society [9, 11]. Thus, monitoring for
the zoonotic pathogens and the AMR in shelter dogs
is important for understanding the risk to the human
population and the environment.
Population of dogs housed in animal shelters are at
increased risk of carrying and spreading a variety of
enteric pathogens to both animals and humans. Some
of the common enteropathogens of dogs are also important public health pathogens. For instance, Camylobacter jejuni (C. jejuni) is a zoonotic pathogen frequently
detected in symptomatic and asymptomatic dogs [12]. A
few studies have reported that living with diarrheic pets
is a risk factor for campylobacteriosis in humans [13–20].

A recent multi-laboratory survey in the United States
showed that 1.3% symptomatic and 1.1% asymptomatic
dogs shed Salmonella in their feces [21]. Similarly, toxin
producing Clostridium perfringens (cpa-positive C. perfringens) is present in diarrheic and healthy dogs and is
also considered as potential zoonotic pathogen [22].
Some factors that contribute to the introduction, persistence, and spread of enteric pathogens in animal shelters include high animal population densities, lack of
proper veterinary care, stressful and unsanitary housing
conditions, limited funding, adoption across state boundaries, and high animal turnover [23]. Cultural and socioeconomic factors unique to the Appalachian Region
further complicate these issues and put these animals at a
risk of getting infected, becoming carriers, and transmitting diseases to both animals and humans. The objective
of this study was to detect occurrence of zoonotic enteropathogens including C. jejuni, Salmonella, cpa-positive
C. perfringens and cephalosporin resistant (CefR) enteric
bacteria in the feces of dogs (owner surrender, free-roaming, feral) housed in ten animal shelters across three US
states within the Central and South-Central Appalachian
Region.

Results
Population demographics

Animal attributes of shelter location, sex (male or
female), estimated age, and fecal score were recorded at
the time of sampling (Table 1). The dogs sampled in this
study included 23 (39%) female, 36 (61%) male, and had a

Table 1 Demographics of shelter dogs carrying CefR enteric bacteria
Sample ID

Shelter
ID

Breed

Age
(years)

Sex

Fecal Score

Bacterial isolates

MALDI
scores

CR01

KR

Pit mix

2

f

6

E. coli

2.51

CR02

KR

Lab mix

2

m

4

E. coli

2.40

CR03

LC

Pitbull

1

m

2

E. coli

2.54

CR04

LC

Rottweiler mix

4

m

3

E. coli

2.49

CR05

LC

Australian shepherd mix

3

m

2

E. coli

2.33

CR06

UC

Collie mix

0.17

m

3

E. coli

2.56

CR07

UC

Collie mix

0.3

f

3

E. coli

2.49

CR08

SL

Chihuahua

5

m

3

E. coli

2.49

CR09

SL

Lab

1.5

m/n

3

E. coli

2.58

CR11

SL

Pitbull

3

m

5

E. coli

2.41

CR12

SL

Pit/Shepherd mix

1

m

3

E. coliEnterococcus hirae

2.52
2.32

CR13

SL

Hound

1

m

3

E. coli

2.33

CR14

JO

Beagle mix

3

f

2

Acinetobacter baumannii

2.32

CR15

JO

Collie

2

f

2

Acinetobacter pittii
Pseudomonas aeruginosa

2.35
2.46

CR16

KW

Border Collie

0.42

m

6

E. coli

2.44

CR17

KW

Chihuahua mix

2

f

2

E. coli

2.51
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Fig. 1 CefR enteric bacteria among shelter dogs. Map depicts the dog shelters in the US states of Kentucky, Tennessee, and Virginia. Fecal samples
were collected from 8 dogs from Shelter WT, 7 dogs from Shelter KW, 6 dogs each from Shelters KR, BC, CC, LC, UC, SL, JO, and 2 dogs from Shelter
BR. The proportions of CefR enteric bacteria within each shelter pie chart is shown. Map created with ArcMap 10.6 (Esri, Redlands, CA)

mean age of 2.2 years (range 2 months to 10 years), and a
mean fecal score of 2.95 (range 1-6; Purina Fecal Scoring
Scale). A fecal score of 1 indicates a hard and dry stool, 3
is normal, and a fecal score of 6 is indicative of a watery
stool with no solid composition.
Occurrence of C. jejuni, C. perfringens and Salmonella
in shelter dogs

Of the 59 dogs tested in this study, 8 (13.6%; 95% CI:
6-30%) and 14 (23.7%; 95% CI: 13.6-36.6%) were positive
for the hipO and cpa genes of C. jejuni and C. perfringens,
respectively (Fig. 1). Three dogs were positive for both C.
jejuni and C. perfringens. None of the dogs were positive
for Salmonella by culture or by PCR methods. Out of 10
shelters, C. jejuni was detected in fecal samples collected
from 3 (30%) shelters while cpa-positive C. perfringens
was detected in fecal samples collected from 7 (70%)
shelters. C. jejuni was detected most frequently in the
fecal samples (4/8, 50%) collected from KR shelter. Many

of the expected counts for chi-square tests were less than
5 due to the low number of samples and positive results
except for C. perfringens and sex which was not statistically significant. Therefore, no statistical interpretation
can be made regarding the other variables and test results
for the sampled shelter dogs.
Occurrence of Ceftiofur‑resistant enteric bacteria

MALDI scores of CefR fecal isolates obtained in this study
ranged from 2.32 to 2.56, allowing species-specific identification (Table 1). CefR resistant enteric bacteria were isolated from six (60%) out of the ten shelters sampled in this
study. Of the 59 dogs sampled in this study, 16 (27.1%;
95% CI: 16.4-40.3%) tested positive for carriage of C
 efR
R
bacteria. These 16 dogs yielded a total of 18 C
 ef resistant
enteric bacteria (Table 1). A single/mono culture of CefR
E. coli was isolated from 13 out of 16 dogs (81.2%). The
remaining three dogs (18.8%) yielded a mono culture of
Acinetobacter baumannii (dog ID: CR14), mixed culture
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Fig. 2 Antimicrobial resistance of bacterial isolates

of CefR E. coli and Enterococcus hirae (dog ID: CR12) and
a mixed culture of Acinetobacter pitii and Pseudomonas
aeruginosa (dog ID: CR15). Among the 
CefR-positive
dogs, the mean age was 1.9 years (range 2 months to 5
years), and the mean fecal score was 3 (range 2-6). Of
note, 5 out of 6 (83.33%) samples from shelter SL demonstrated cephalosporin resistance, accounting for nearly
32% of all C
 efR bacteria isolated in this study. Only the
variables sex and shelter when analyzed at the state-level
had any statistical meaning due to small sample size and
number of positives. State-level analysis showed a significant difference (p-value = 0.049) among the three
states in terms of dogs having CefR enteric bacteria. At
the state-level, Tennessee reported 45.8% (11/24; 95% CI:
25.6-67.2%), followed by Kentucky (4/19, 21.2%; 95% CI:
6.1-45.6%), and Virginia (2/16, 12.5%; 95% CI: 1.6-38.4%).
Shelter SL is located within Tennessee which likely influenced the results.
Occurrence of antimicrobial resistance

Antimicrobial susceptibilities of CefR isolates (n=18) to a
broad range of antibiotics that are relevant to companion
animals were tested. CefR enteric bacteria isolated in this
study also showed resistance to amoxicillin-clavulanate
(n=17), ampicillin (n=14), cefazolin (n=18), cefpodoxime (n=14), ceftazidime (n=14), chloramphenicol (n=2),

doxycycline (n=8), gentamicin (n=2), piperacillin (n=2),
tetracycline (n=9), and trimethoprim/sulfamethoxazole
(n=3) (Fig. 2).
Seventeen (94.4%) C
 efR isolates were resistant to more
than one antibiotic (Fig. 3). Of the 14 E. coli isolates, 11
(78.6%) isolates exhibited MDR phenotype (resistance to
three or more antibiotic classes). All E. coli isolates demonstrated resistance to amoxicillin/clavulanic acid, ampicillin, cefazolin, cefpodoxime, and ceftazidime. Eight out
of 14 E. coli isolates were resistant to doxycycline; 9/14
to tetracycline; 3/14 to trimethoprim/sulfamethoxazole,
2/14 to gentamicin and piperacillin, and 1 to chloramphenicol (Fig. 3). One E. coli isolate (CR03) demonstrated
resistance to 9 of the tested antimicrobials (Fig. 3). Isolates from different dogs within a same shelter had same
antimicrobial resistance profiles, for example, isolates
CR06 and CR07 (shelter UC); CR08, CR09, CR11, CR12,
and CR13 (shelter SL); CR14 and CR15A (shelter JO);
CR16 and CR17 (shelter KW) (Fig. 3).

Discussion
Zoonotic and MDR enteric bacteria in shelter dogs pose
a serious animal and public health concern. These dogs
could serve as a reservoir of infections for other dogs,
shelter worker or potential adopters. As noted earlier, some antimicrobials, such as extended spectrum
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Fig. 3 Multi-drug resistance patterns of individual bacterial isolates

cephalosporins, are listed as critical antibiotics for treating bacterial infections in both humans and animals [2,
3]. The occurrence of C
 efR enteric bacteria in shelter dogs
in this study was 27.1% (16/59). These data corroborate
with a recent study conducted in Ontario, Canada where
average frequency of fecal carriage of CefR enteric bacteria in apparently healthy dogs was 26.5% [24].
The approach of initial selection for resistance to the
third-generation cephalosporin (ceftiofur), has been
used previously in cattle and poultry [25, 26]. Here, we
employed similar approach to selectively isolate enteric
bacteria that are not only resistant to cephalosporins, but
also resistant to other antibiotic classes. For instance, 11
out of 14 E. coli isolates recovered in this study displayed
MDR phenotype. The other common resistances noted
in these isolates were against classes of antimicrobials
that have been used for decades: penicillin, sulfonamide,
aminoglycosides, and tetracycline. These findings are also
consistent with those of Zhang et al (2018) in their study
of fecal samples from dog parks and clinical settings.
A statistical association was found between the shelter of provenance and the presence of AMR in feces of

the sampled dogs. While shelter characteristics were not
recorded, the authors informally observed the shelters
while collecting the samples. The shelters varied greatly
in size, age of construction, training of personnel, stocking density, and overall perception of cleanliness. Interestingly, there were similar resistance profiles present
within the population of individual shelters. For instance,
E. coli isolates CR06 and CR07 in shelter UC, E. coli isolates CR08, CR09, CR11, CR12, and CR13 in shelter SL,
E. coli isolates CR16 and CR17 in shelter KW, and A. baumannii and A. pittii isolates CR14 and CR15A in shelter
JO had similar resistance profiles. These data suggest
that dog-to-dog or point source transmission was likely
occurring via environmental contamination or direct
contact during socialization, even though the dogs were
individually housed within each shelter. This provides an
area for future investigation covering biosecurity, housing design, education, and disinfection processes to elucidate the horizontal transmission of resistant bacteria.
In addition, we found that 8 (13.5%) and 14 (23.7%)
fecal samples tested in this study were positive for C.
jejuni and cpa-positive C. perfringens. Both C. jejuni
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and C. perfringens are considered zoonotic pathogens
[12, 22]. Although likely, it is currently unknown if
any of these bacteria are transmitted from shelter dogs
or environment to other dogs or people in proximity within these shelters. Other research groups have
demonstrated the potential for transmission of different bacterial pathogens between dogs and humans.
Recently, 78% of the Staphylococcus spp. isolated from
healthy dogs were reported to exhibit multi-drug resistance [6, 27]. Guardabassi and colleagues reported that
46% of pet owners carried the same strain of Staphylococcus pseudintermedius as their dogs with deep pyoderma [6]. Similarly, other studies have also reported
transmission of methilicin-resistant staphylococci from
companion dogs to people in close proximity [28, 29].
Between 2016-2019, CDC reported two MDR Campylobacter outbreaks, which included almost 150 human
cases, linked to contact with pet store puppies [30].
Although Salmonella was not detected in our study,
zoonotic transmission of Salmonella from dogs to
human has been reported [31–36]. The carriage and
potential for transmission of zoonotic bacterial pathogens such as Campylobacter between clinically ill companion animals and humans is not a novel concept [19,
37]. However, this data shows that apparently healthy
shelter dogs can be carriers of zoonotic and MDR
enteric bacteria and may pose a hazard for pet owners, an increased occupational risk for animal care and
veterinary staff, as well as a need for further research
on this topic. Several bacterial species isolated in this
study are known opportunistic human pathogens. For
example, dog feces serve as a potential reservoir for E.
coli with potential for extraintestinal infections such
as urinary tract infections in humans [38–40]. The
pathogen-AMR combinations detected in the current
study have been identified as significant human pathogens under GLASS surveillance [41]. The results of
interest include E. coli with resistance to penicillins,
third and fourth generation cephalosporins, sulfonamides/trimethoprim. Although Acinetobacter spp. is on
the GLASS surveillance list, the isolates in this study
showed resistance only to penicillins and cephalosporins, which are not the antibiotic classes of interest. The
ecology, epidemiology, and potential public health significance of the organisms in this specific situation of
animal shelters is currently unknown and requires further investigation [42, 43].
One of the inherent limitations for this study is the lack
of medical history for each dog. For example, the prior
antimicrobial use of these dogs is unknown, as they were
an undisclosed mix of captured and owner-surrendered
dogs. It is worthwhile to note that exposure to multiple antimicrobials is not uncommon in many shelter
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situations [44] as upper respiratory (canine infectious
respiratory disease-CIRD), gastrointestinal and heartworm diseases are frequently encountered in shelters.
Broad-spectrum antibiotics such as doxycycline, may be
used as part of treatment regimen for the above conditions [45]. Additional antibiotic treatments in shelters
include amoxicillin-clavulanate, azithromycin, enrofloxacin, and trimethoprim-sulfonamide [46]. These antibiotics can select for multi-drug resistant bacteria within the
shelter population, which may explain why resistance
against all of these antibiotics were observed in the isolates in our study. It is possible that use of one or more
antibiotics may have not only selected for MDR bacteria
in the dogs screened in this study, but also leading to persistence and potential transmission between dogs.

Conclusions
The results of this study show that shelter dog population can serve as a potential reservoir for zoonotic and
MDR enteric bacteria and raise a possibility transmission
to humans in proximity. Noting that many shelters allow
the volunteers and general public to interact freely with
these animals prior to adoption, the potential risk may
not be just limited to the shelter staff. In case of vulnerable groups (geriatric, immunocompromised, undergoing chemotherapy), a screening protocol for zoonotic and
AMR pathogens prior to adoption may be considered.
Microbiome diagnostics may be of value in these situations and their usefulness is currently under investigation
in our lab.
Methods
Ethics statement

This study was conducted on freely voided fecal samples collected under a protocol that was exempted by
the Institutional Animal Care and Use Committee at
the Lincoln Memorial University. Informed consent was
obtained from the animal shelter directors to collect and
use the fecal samples for research.
Sample collection

During Summer 2019, fecal samples were collected from 59
apparently healthy dogs, varying in sex and age, housed in
10 different shelters in the Appalachian Region of Kentucky,
Tennessee, and Virginia (Fig. 4). The animals were apparently healthy, of varied ages and sexes at the time of sample
collection. Fresh fecal samples (9-50 g) were collected from
freshly voided samples in the individual kennel. Upon collection into plastic zip-top bags, samples were immediately
placed on ice and transported to the lab for further processing. Demographic information including shelter location,
animal age, breed, sex, and fecal score (Purina scale) were
recorded for each dog (Table 1).
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Fig. 4 PCR identification of C. jejuni and cpa-positive C.perfringens. For C. jejuni identification A: Lanes 1 and 19, C. jejuni genomic DNA; lanes 2 and
18, 100bp DNA ladder; lanes 3 and 17, no template control; lanes 4, 5, 6, 7, 10, 11, 15 and 16, C. jejuni hipO positive samples; lanes 8, 9, 12, 13 and 14,
C. jejuni hipO gene negative samples. For C. perfringens identification. Samples in lanes 1-10 and 11-19 were run on the top and bottom halves of the
same gel, respectively. B: Lanes 1 and 20, C. perfringens genomic DNA; lanes 2 and 19, 100bp DNA ladder; lanes 3 and 18, no template control; lanes
4, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14, 15, 16 and 17, C. perfringens cpa gene positive samples. Lane 15 has a faint band. All samples were tested at least
twice. Samples in lanes 1-10 and 11-20 were run on the top and bottom halves of the same gel, respectively

PCR screening for C. jejuni, C. perfringens and Salmonella

Total genomic DNA was extracted from each fecal sample (n=59) using QIAamp DNA Stool Mini Kit following manufacturer’s instructions (Qiagen, Germantown,
MD). Extracted DNA were quantified and screened for
detection of C. jejuni, C. perfringens and Salmonella by
PCR as follows. For the detection of C. jejuni, a PCR targeting hipO gene was used as described previously [47].
Each 25 μL PCR reaction contained 1.25 U FastStart Taq
Polymerase (Roche Diagnostics), 1X PCR buffer (Applied
Biosystems), 0.2 μM hipO-F (5’ GACTTCGTGCAGATA
TGGATGCTT), 0.2 μM hipO-R (5’ GCTATAACTATC
CGAAGAAGCCATCA), 5 μL of fecal DNA, and thermal conditions as described previously [47]. For amplification of cpa gene from C. perfringens, each 25 μL PCR
mixture consisted of 12.5 μL of DreamTaq PCR master mix (Thermo Fisher Scientific, CA, USA), 0.25 μM
cpa1F primer (5′-GCTAATGTTACTGCCGTTGA-3′),
0.25 μM cpa1R primer (5′-CCTCTGATACATCGTGTA
AA-3′), and 1 μL of fecal DNA. The PCR was performed
following method described previously [48]. PCR product size for C. perfringens was 324 bp. For PCR detection

of Salmonella, a well-conserved Salmonella gene invA
was targeted, as described previously [48]. Briefly, each
25 μL reaction consisted of 0.04 μM invA_F primer (5′
GTGTCCTTTGGTATTAATCC-3′), 0.04 μM invA_R
(5′-GTCTGAGCACTTCTTTAAG-3′) primer, 12.5 μL
of DreamTaq PCR master mix (Thermo Fisher Scientific,
CA, USA), and 2 μL of fecal DNA. The thermal conditions consisted of 95 °C for 5 min, followed by 39 cycles
of 20 s at 95 °C, 20 s at 54 °C, 20 s at 72 °C, and a final
for 5 min at 72 °C. PCR product size for Salmonella was
250 bp. Positive controls (genomic DNA extracted from
a reference strain of each tested bacteria) and negative
control (water) were included during each PCR run. PCR
amplicons were analyzed by 1.5% agarose gel electrophoresis under standard conditions and stained by GelGreen
Nucleic Acid Gel Stain (Biotium, Inc., Fremont, CA).
Isolation of salmonella

For isolation of Salmonella, 1 g of fecal sample was
resuspended in 10 ml of buffered peptone water (BPW)
and incubated overnight at 37°C for 24 h. Subsequently,
10 drops of sample-BPW suspension were transferred
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to 10 ml of iodine-supplemented tetrathionate broth
(TTB, Hardy Diagnostics) and incubated at 37°C for 24
h. Next, 10 μl of sample-TTB suspension was inoculated
on XLT-4 agar (Hardy Diagnostics) plates and plates were
incubated at 37°C for up to 24 h. Suspect Salmonella
colonies were purified by replica plating and stored at
−80°C in 15% (v/v) phosphate-buffered glycerol.
Isolation of ceftiofur‑resistant enteric bacteria

One gram of fecal sample was resuspended in 5 ml of
phosphate buffered saline (PBS) and incubated at room
temperature for 5 min. Fifty and 150 μl of sample were
transferred onto a MacConkey agar plate supplemented
with Ceftiofur (8 μg/ml) and evenly spread over the surface of the agar as described previously [25]. The plates
were then incubated at 37°C for 15 to 18 h. Two to three
colonies representing a unique colony morphotype were
selected, transferred to 5 ml LB containing Ceftiofur (8
μg/ml), mixed well and then incubated again at 37°C for
15 to 18 h. Following incubation, the cultures were preserved in 15% (v/v) glycerol and frozen at -80°C. Approximately 1 μl of the sample was taken from the frozen
stock, streaked onto a blood agar plate, and incubated at
37°C for 15 to 18 h. These plates were used for identification and characterization of isolates.
Identification and characterization of isolates

The individual colonies from pure cultures were identified by MALDI-TOF (Bruker, Billerica, MA) following
manufacturer’s instructions. The bacteria with scores
above 2.0 were identified at the species level. The isolates from pure cultures underwent antimicrobial susceptibility testing by broth microdilution method using
commercial plates (COMPGN1F and COMPGP1F, Trek
Sensititer; ThermoFisher Scientific, Grand Island, NY,
USA) in accordance to the guidelines established by the
Clinical and Laboratory Standard Institute (CLSI, 2017).
The concentrations (μg/ml) of the antimicrobials in
COMPGN1F panel included Amikacin (4 – 32); Amoxicillin / clavulanic acid 2:1 ratio (0.25/0.12 – 8/4); Ampicillin (0.25 – 8); Cefazolin (1 – 32); Cefovecin (0.25 – 8);
Cefpodoxime (1 – 8); Ceftazidime (4 – 16); Cephalexin
(0.5 – 16); Chloramphenicol (2 – 32); Doxycycline (0.25
– 8); Enrofloxacin (0.12 – 4); Gentamicin (0.25 – 8); Imipenem (1 – 8); Marbofloxacin (0.12 – 4); Orbifloxacin
(1 – 8); Piperacillin / tazobactam (8/4 – 64/4); Pradofloxacin (0.25 – 2); Tetracycline (4 – 16); Trimethoprim/
sulfamethoxazole (0.5/9.5 – 4/76). The concentration
of antimicrobials in COMPGP1F panel included Amikacin (16 – 32); Amoxicillin / clavulanic acid 2:1 ratio
(0.25/0.12 – 8/4); Ampicillin (0.25 – 8); Cefazolin (2 – 4);
Cefovecin (0.06 – 8); Cefpodoxime (2 – 8); Cephalothin
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(2 – 4); Chloramphenicol (8 – 32); Clindamycin (0.5 – 4);
Doxycycline (0.12 – 0.5); Enrofloxacin (0.25 – 4); Erythromycin (0.25 – 4); Gentamicin (4 – 16); Imipenem
(1 – 4); Marbofloxacin (1 – 4); Minocycline (0.5 – 2);
Nitrofurantoin (16 – 64); Oxacillin+2%NaCl (0.25 – 2);
Penicillin (0.06 – 8); Pradofloxacin (0.25 – 2); Rifampin
(1 – 2); Tetracycline (0.25 – 1); Trimethoprim/sulfamethoxazole (2/38 – 4/76); Vancomycin (1 – 16). S. aureus
ATCC 29213, Streptococcus pneumoniae ATCC 46619,
Enterococcus faecalis ATCC 29212, or Escherichia coli
ATCC 25922 were tested weekly as quality assurance
to validate the test. The interpretation of antimicrobial
susceptibilities was based upon the most recent CLSI
guidelines as provided by the manufacturer. For E. coli,
the isolate that were resistant to three or more antibiotic
classes were labeled as MDR following the CDC-NARMS
guidelines (https://www.cdc.gov/narms/resources/gloss
ary.html). Because of their intrinsic antibiotic resistance,
Pseudomonas spp. and Acinetobacter spp. were labeled
MDR only if they were resistant to two or more of antibiotic classes for which they are not known to be intrinsically resistant (Shah et al., 2019).
Statistical analysis

Statistical analysis was performed using SPSS 26 (IBM,
New York). Briefly, test results for C. perfringens, C.
jejuni and CefR enteric bacteria were compared to variables: shelter location, age, sex, and fecal score using
chi-square test or Fisher’s exact test. Breed was not
included in analysis due to too much variation in data
collected. Additionally, shelter locations were grouped
at state-level and dogs were categorized as < 1 year old
or ≥ 1 year old to improve results of statistical analysis.
A p-value of <0.05 was considered significant.
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